Al-Majed Abdulhakeem A
Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Basic Clin Pharmacol Toxicol. 2007 Mar;100(3):145-50. doi: 10.1111/j.1742-7843.2006.00024.x.
This study investigates whether or not carnitine deficiency is a risk factor and could contribute to cisplatin-induced liver toxicity. A total of 60 adult male Wistar albino rats were divided into six groups. The first three groups were injected intraperitoneally with normal saline, propionyl-l-carnitine (500 mg/kg), and d-carnitine (500 mg/kg), respectively, for 10 successive days. The fourth, fifth and sixth groups were injected intraperitoneally with the same doses of normal saline, propionyl-l-carnitine and d-carnitine, respectively, for 5 successive days before and after a single dose of cisplatin (7 mg/kg). Administration of the standard nephrotoxic dose of cisplatin did not produce any changes in serum alanine transaminase and gamma-glutamyl transferase and no morphological changes in liver tissues. However, it did produce a significant increase in thiobarbituric acid reactive substances and total nitrate/nitrite and a significant decrease in reduced glutathione content in liver tissues. On the other hand, combined treatment with cisplatin and d-carnitine induced a dramatic increase in serum alanine transaminase and gamma-glutamyl transferase, as well as progressive reduction in total carnitine and ATP content in liver tissue. Moreover, histopathological examination of liver tissues confirmed the biochemical data, where cisplatin and d-carnitine combination showed signs of liver injury manifested as focal necro-inflammatory changes and portal inflammation. Interestingly, in carnitine supplemented rats using propionyl-l-carnitine, cisplatin did not produce any biochemical and histopathological changes in liver tissues. In conclusion, data from this study suggest for the first time that (1) carnitine deficiency is a risk factor and could precipitate cisplatin-induced hepatotoxicity, (2) oxidative stress is not the main cause of cisplatin-related hepatotoxicity and (3) propionyl-l-carnitine prevents the development of cisplatin-induced liver injury.
本研究调查了肉碱缺乏是否为一种风险因素以及是否会导致顺铂诱导的肝毒性。总共60只成年雄性Wistar白化大鼠被分为六组。前三组分别连续10天腹腔注射生理盐水、丙酰-L-肉碱(500毫克/千克)和D-肉碱(500毫克/千克)。第四、五、六组在单次注射顺铂(7毫克/千克)之前和之后分别连续5天腹腔注射相同剂量的生理盐水、丙酰-L-肉碱和D-肉碱。给予标准肾毒性剂量的顺铂未引起血清丙氨酸转氨酶和γ-谷氨酰转移酶的任何变化,肝脏组织也未出现形态学改变。然而,它确实导致肝脏组织中硫代巴比妥酸反应性物质和总硝酸盐/亚硝酸盐显著增加,还原型谷胱甘肽含量显著降低。另一方面,顺铂与D-肉碱联合治疗导致血清丙氨酸转氨酶和γ-谷氨酰转移酶急剧增加,以及肝脏组织中总肉碱和ATP含量逐渐降低。此外,肝脏组织的组织病理学检查证实了生化数据,其中顺铂与D-肉碱联合显示出肝损伤迹象,表现为局灶性坏死性炎症改变和门脉炎症。有趣的是,在使用丙酰-L-肉碱补充肉碱的大鼠中,顺铂未在肝脏组织中产生任何生化和组织病理学变化。总之,本研究数据首次表明:(1)肉碱缺乏是一种风险因素,可促使顺铂诱导的肝毒性发生;(2)氧化应激不是顺铂相关肝毒性的主要原因;(3)丙酰-L-肉碱可预防顺铂诱导的肝损伤的发生。